18251227. SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19 simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)
Jump to navigation
Jump to search
Contents
SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19
Organization Name
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Inventor(s)
Deependra Kumar Ban of San Diego CA (US)
Ratneshwar Lal of La Jolla CA (US)
SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19 - A simplified explanation of the abstract
This abstract first appeared for US patent application 18251227 titled 'SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19
Simplified Explanation
Abstract: The patent application describes methods, systems, and devices related to siRNA-based nanobowl-mediated intervention for COV-ID-19.
- siRNA-based nanobowl-mediated intervention for COV-ID-19 is the focus of the patent application.
- The methods, systems, and devices described in the patent application aim to provide a novel approach for combating COV-ID-19.
- The intervention involves the use of small interfering RNA (siRNA) delivered through nanobowls.
- The siRNA is designed to target specific genes or viral components of COV-ID-19.
- The nanobowls act as carriers to deliver the siRNA to the target cells.
- The patent application provides details on the design and synthesis of the siRNA and nanobowls.
- The methods, systems, and devices described in the patent application have potential applications in the treatment and prevention of COV-ID-19.
Potential Applications:
- Treatment of COV-ID-19: The siRNA-based nanobowl-mediated intervention can be used as a therapeutic approach to treat individuals infected with COV-ID-19.
- Prevention of COV-ID-19: The intervention can also be utilized as a preventive measure to reduce the risk of COV-ID-19 infection.
- Research and Development: The methods, systems, and devices described in the patent application can be used in research and development efforts related to COV-ID-19.
Problems Solved:
- Lack of effective treatments: The siRNA-based nanobowl-mediated intervention provides a potential solution to the lack of effective treatments for COV-ID-19.
- Limited preventive measures: The intervention offers a new approach to prevent COV-ID-19 infection, addressing the limited preventive measures available.
Benefits:
- Targeted intervention: The siRNA-based approach allows for targeted intervention by specifically targeting genes or viral components of COV-ID-19.
- Enhanced delivery: The use of nanobowls as carriers improves the delivery of siRNA to the target cells, increasing the effectiveness of the intervention.
- Potential versatility: The methods, systems, and devices described in the patent application can be adapted for use with other viral infections, potentially providing a versatile solution.
Original Abstract Submitted
Provided are methods, systems, and devices that pertain to siRNA-based nanobowl-mediated intervention for COV-ID-19.